James A. Lyon

543 citations
15 papers · 335 indexed · h-index 10
Topics
Antibiotics Pharmacokinetics and Efficacy (6 papers)Pneumonia and Respiratory Infections (3 papers)Antibiotic Resistance in Bacteria (3 papers)

In The Last Decade

James A. Lyon

15 papers receiving 296 citations

Peers

James A. Lyon
Comparison fields: 5 of 74
  • Pharmacology 150
  • Epidemiology 83
  • Surgery 80
  • Molecular Medicine 53
  • Molecular Biology 37
Replace P. Olschewski with:
P. Olschewski Germany
R W Schultz United States
J. I. Dahlager Denmark
Darcy Paige United States
Stephanie Durso Italy
C. F. Speirs United Kingdom
Pengmei Li China
Douglas Allington United States
David Hoelscher United States
N. V. Jiménez Spain
James A. Lyon relative to P. Olschewski Germany P. Olschewski's profile →
Citations per field
00.5×4.2×
P. Olschewski · 1×
Citations per year

Countries citing papers authored by James A. Lyon

Since Specialization
Citations

This map shows the geographic impact of James A. Lyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Lyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Lyon more than expected).

Fields of papers citing papers by James A. Lyon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Lyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Lyon. The network helps show where James A. Lyon may publish in the future.

Co-authorship network of co-authors of James A. Lyon

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Lyon. A scholar is included among the top collaborators of James A. Lyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Lyon. James A. Lyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 60
3 44
4 40
5 30
6 1
7 27
8 1
9 36
10 10
11 27
12 3
13 7
14 12
15 36

About James A. Lyon

James A. Lyon is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 15 papers that have together received 335 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pneumonia and Respiratory Infections (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Molecular Medicine (53 citations), Pharmacology (150 citations) and Oral Surgery (33 citations). James A. Lyon has collaborated with scholars based in United States, Egypt and Belgium. Frequent co-authors include Pamela D. Garzone, Victor L. Yu, Donald C. McLeod, Stephen J. Peroutka, James Swarbrick, Victor L. Yu, John R. Zuniga, Gene E. Watson, Daniel A. Shugars and Theodore A. Kiersch. Their work appears in journals such as Radiology, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026